Shivam Kapoor
Research Subjects
Shivam Kapoor has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Pranay Lal
Independent Public Health Consultant, New Delhi, India
4 shared publications- Amit Yadav
Vital Strategies, New Delhi, India
3 shared publications Amit Yadav
International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Office, New Delhi, India
2 shared publications- Ashish Kumar Pandey
Vital Strategies, New York, New York, USA
2 shared publications - Puneet Chahar
Tobacco Control, Vital Strategies, New Delhi, India
2 shared publications Anushikha Dhankhar
Employees' State Insurance Corporation Model Hospital cum ODC, MIDC Central Road, Andheri East, Mumbai, Maharashtra, 400093, India
1 shared publication
Latest Publications
- 5 October 2026
- Published by BMJ in Tobacco Control
Understanding bidi industry from the lenses of bidi workforce: an exploratory study
Introduction: Bidis (small hand-rolled cigarillos) account for 85% of smoked tobacco products in India. The bidi industry is criticised for health hazards, economic exploitation, poor social security, long hours, low wages and contractualisation. This study examines bidi industry practices in India and how these allow it to resist tobacco control measures. Methods: The study was conducted in Murshidabad (West Bengal) and Jabalpur/Narsinghpur (Madhya Pradesh) districts, which were selected for their significant bidi roller populations. Interviews were conducted with 200 bidi rollers and 17 key stakeholders, including munshis (middle-men/intermediaries), community/youth club representatives and labour union leaders, with assistance from 10 ‘champions’ (trusted community insiders). Participants provided informed consent and their confidentiality was ensured. Interview data, in Bangla and Hindi, were translated into English and then analysed thematically. Findings: Five major themes emerged. First, bidi companies engage in image-building corporate social responsibility activities that mirror tactics used by multinational cigarette companies, creating a facade of social responsibility while exploiting workers. Second, the industry systematically violates government policies through wage discrepancies, provident fund fraud and false worker registration to evade compliance. Third, systemic inequity pervades the sector, with median wages at only 38–53% of government-mandated rates. Fourth, unjustified bidi rejections facilitate widespread illicit trade that evades taxation and government oversight. Fifth, child labour remains entrenched in West Bengal. Conclusion: Bidi companies’ current practices perpetuate labour exploitation and illicit trade. We recommend uniform national guidelines that require transparent operations and mandatory registration of all bidi rollers.
- 5 October 2026
- Published by BMJ in Tobacco Control
Understanding bidi industry from the lenses of bidi workforce: an exploratory study
Introduction: Bidis (small hand-rolled cigarillos) account for 85% of smoked tobacco products in India. The bidi industry is criticised for health hazards, economic exploitation, poor social security, long hours, low wages and contractualisation. This study examines bidi industry practices in India and how these allow it to resist tobacco control measures. Methods: The study was conducted in Murshidabad (West Bengal) and Jabalpur/Narsinghpur (Madhya Pradesh) districts, which were selected for their significant bidi roller populations. Interviews were conducted with 200 bidi rollers and 17 key stakeholders, including munshis (middle-men/intermediaries), community/youth club representatives and labour union leaders, with assistance from 10 ‘champions’ (trusted community insiders). Participants provided informed consent and their confidentiality was ensured. Interview data, in Bangla and Hindi, were translated into English and then analysed thematically. Findings: Five major themes emerged. First, bidi companies engage in image-building corporate social responsibility activities that mirror tactics used by multinational cigarette companies, creating a facade of social responsibility while exploiting workers. Second, the industry systematically violates government policies through wage discrepancies, provident fund fraud and false worker registration to evade compliance. Third, systemic inequity pervades the sector, with median wages at only 38–53% of government-mandated rates. Fourth, unjustified bidi rejections facilitate widespread illicit trade that evades taxation and government oversight. Fifth, child labour remains entrenched in West Bengal. Conclusion: Bidi companies’ current practices perpetuate labour exploitation and illicit trade. We recommend uniform national guidelines that require transparent operations and mandatory registration of all bidi rollers.
- 7 January 2026
- Published by BMJ in Tobacco Control
Tobacco industry’s political contributions in conflict with WHO FCTC Article 5.3 Guidelines: an analysis of publicly available documents from India
Background: Tobacco industry tactics that have proven effective in the past, such as using corporate social responsibility initiatives to curry favour with policymakers, have been examined in India. However, reporting the tobacco industry’s financial contributions to political parties must be closely monitored, and their reporting made transparent. Methods: Document analysis was conducted for: (i) ‘recognised’ national and state political parties in India (as on 15 May 2023), (ii) Electoral Trusts listed by Central Board of Direct Taxes, and (iii) Electoral Bonds, available from the Election Commission of India (ECI) website. Annual contributions from top four publicly listed companies (Bombay Stock Exchange ‘Top 2000 Companies 2023’) and one major non-listed smokeless tobacco company—along with their subsidiaries, associates and joint ventures—were examined. Contribution pathways included direct transfers or indirect routes via Electoral Trusts and Electoral Bonds, spanning 2013–2014 to 2022–2023. Results: A total of 485 (62.2%) of the 780 expected reports of parties and Trusts were available on ECI website. These were analysed for contributions by 103 tobacco companies and their affiliated entities. Tobacco companies had contributed more than US$ 65 million to 17 political parties between 2013 and 2023. The largest contributors were ITC Limited and its subsidiaries—ITC Infotech India and Russell Credit. Conclusions: This study documents a less-discussed area in the Indian landscape of tobacco industry interference and highlights the pressing need for comprehensive implementation of the WHO-Framework Convention on Tobacco Control Article 5.3, to prohibit financial contributions by tobacco companies to political parties in India, and ultimately protect public health.
- 7 January 2026
- Published by BMJ in Tobacco Control
Tobacco industry’s political contributions in conflict with WHO FCTC Article 5.3 Guidelines: an analysis of publicly available documents from India
Background: Tobacco industry tactics that have proven effective in the past, such as using corporate social responsibility initiatives to curry favour with policymakers, have been examined in India. However, reporting the tobacco industry’s financial contributions to political parties must be closely monitored, and their reporting made transparent. Methods: Document analysis was conducted for: (i) ‘recognised’ national and state political parties in India (as on 15 May 2023), (ii) Electoral Trusts listed by Central Board of Direct Taxes, and (iii) Electoral Bonds, available from the Election Commission of India (ECI) website. Annual contributions from top four publicly listed companies (Bombay Stock Exchange ‘Top 2000 Companies 2023’) and one major non-listed smokeless tobacco company—along with their subsidiaries, associates and joint ventures—were examined. Contribution pathways included direct transfers or indirect routes via Electoral Trusts and Electoral Bonds, spanning 2013–2014 to 2022–2023. Results: A total of 485 (62.2%) of the 780 expected reports of parties and Trusts were available on ECI website. These were analysed for contributions by 103 tobacco companies and their affiliated entities. Tobacco companies had contributed more than US$ 65 million to 17 political parties between 2013 and 2023. The largest contributors were ITC Limited and its subsidiaries—ITC Infotech India and Russell Credit. Conclusions: This study documents a less-discussed area in the Indian landscape of tobacco industry interference and highlights the pressing need for comprehensive implementation of the WHO-Framework Convention on Tobacco Control Article 5.3, to prohibit financial contributions by tobacco companies to political parties in India, and ultimately protect public health.
- 12 August 2025
- Published by BMJ in Tobacco Control
Herbal tobacco cessation products on Indian e-commerce platforms: an emerging unregulated market with unsubstantiated health claims
Background Herbal tobacco cessation products (HTCPs), marketed with claims to support tobacco or nicotine cessation, are increasingly sold online in low-income and middle-income countries. However, there is little regulatory oversight or evidence on their safety and effectiveness. This study assessed the availability, affordability, claims and regulation of HTCPs on Indian e-commerce platforms. Methods We systematically searched five major Indian e-commerce platforms (Amazon.in, Flipkart, Blinkit, JioMart and Meesho) using keywords related to herbal tobacco cessation. Product listings were screened and categorised by product type, claimed indications, presence of disclaimers, regulatory approvals and pricing. Findings were summarised descriptively. Results We identified 316 unique HTCPs across 5 major Indian e-commerce platforms. HTCPs were marketed in three primary formulations: combustible products (42.7%), raw herbal preparations (34.5%) and other formats such as gummies, drops, capsules and patches (22.8%). Products featured diverse flavours (eg, Apple, Paan, Gulkand) and varied widely in pricing (Indian National Rupees (INR)15–INR1467; US$0.18–US$17.67), with premium pricing concentrated on Amazon. Notably, 62.3% of HTCPs carried at least one certification or quality claim, including International Organisation for Standardisation (23.4%), Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homoeopathy (20.3%), Good Manufacturing Practice (15.2%) and Food Safety and Standards Authority of India (13.2%). A small fraction (0.5%) referenced WHO affiliation, raising concerns about potentially misleading endorsements. Additionally, 43.7% of products promoted ancillary health claims such as detoxification or anxiety relief. Only 12% of products displayed age restrictions, and none had functional age verification mechanisms. Conclusions HTCPs are widely available on Indian e-commerce platforms with unverified health claims and minimal regulatory disclosure. This poses significant consumer protection and tobacco control challenges. Strengthened oversight, claim verification and policy alignment with WHO Framework Convention on Tobacco Control guidelines are urgently needed.
- 12 August 2025
- Published by BMJ in Tobacco Control
Herbal tobacco cessation products on Indian e-commerce platforms: an emerging unregulated market with unsubstantiated health claims
Background Herbal tobacco cessation products (HTCPs), marketed with claims to support tobacco or nicotine cessation, are increasingly sold online in low-income and middle-income countries. However, there is little regulatory oversight or evidence on their safety and effectiveness. This study assessed the availability, affordability, claims and regulation of HTCPs on Indian e-commerce platforms. Methods We systematically searched five major Indian e-commerce platforms (Amazon.in, Flipkart, Blinkit, JioMart and Meesho) using keywords related to herbal tobacco cessation. Product listings were screened and categorised by product type, claimed indications, presence of disclaimers, regulatory approvals and pricing. Findings were summarised descriptively. Results We identified 316 unique HTCPs across 5 major Indian e-commerce platforms. HTCPs were marketed in three primary formulations: combustible products (42.7%), raw herbal preparations (34.5%) and other formats such as gummies, drops, capsules and patches (22.8%). Products featured diverse flavours (eg, Apple, Paan, Gulkand) and varied widely in pricing (Indian National Rupees (INR)15–INR1467; US$0.18–US$17.67), with premium pricing concentrated on Amazon. Notably, 62.3% of HTCPs carried at least one certification or quality claim, including International Organisation for Standardisation (23.4%), Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homoeopathy (20.3%), Good Manufacturing Practice (15.2%) and Food Safety and Standards Authority of India (13.2%). A small fraction (0.5%) referenced WHO affiliation, raising concerns about potentially misleading endorsements. Additionally, 43.7% of products promoted ancillary health claims such as detoxification or anxiety relief. Only 12% of products displayed age restrictions, and none had functional age verification mechanisms. Conclusions HTCPs are widely available on Indian e-commerce platforms with unverified health claims and minimal regulatory disclosure. This poses significant consumer protection and tobacco control challenges. Strengthened oversight, claim verification and policy alignment with WHO Framework Convention on Tobacco Control guidelines are urgently needed.
- Open Access
- 31 July 2024
- Published by Elsevier in Data in Brief
- Vol. 56, 110782
Estimating the annual production data of bidi sticks in India using the “back-of-the-envelop-method”
- 31 July 2024
- Published by Elsevier in Data in Brief
- Vol. 56, 110782
Open AccessEstimating the annual production data of bidi sticks in India using the “back-of-the-envelop-method”
- 15 September 2023
- Published by Elsevier
- p. 199-218
Wastewater treatment-associated bioaerosols: an emerging health threat
- 15 September 2023
- Published by Elsevier
- p. 199-218
Wastewater treatment-associated bioaerosols: an emerging health threat
- 3 June 2023
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 71 (3) , 297-303
Compliance to the Tobacco-Free Educational Institution(ToFEI) guidelines at Madhyamik Vidhyalayas of Pimpri-Chinchwad, Pune, Maharashtra-A cross sectional study
- 3 June 2023
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 71 (3) , 297-303
Compliance to the Tobacco-Free Educational Institution(ToFEI) guidelines at Madhyamik Vidhyalayas of Pimpri-Chinchwad, Pune, Maharashtra-A cross sectional study
- Open Access
- 11 July 2022
- Published by Medknow in Indian Journal of Community Medicine
- Vol. 47 (2) , 296-298
The Challenge of Motivating Bidi Smokers to Quit by Approaching Them Even When They Say They Are Not Ready to Quit
Indian Journal of Community Medicine, the official organ of the Indian Association of Preventive and Social Medicine (IAPSM), India
- 11 July 2022
- Published by Medknow in Indian Journal of Community Medicine
- Vol. 47 (2) , 296-298
Open AccessThe Challenge of Motivating Bidi Smokers to Quit by Approaching Them Even When They Say They Are Not Ready to Quit
Indian Journal of Community Medicine, the official organ of the Indian Association of Preventive and Social Medicine (IAPSM), India
- 1 November 2021
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 22 (S2) , 51-57
Banning Loose Cigarettes and Other Tobacco Products in India: A Policy Analysis
Background: Sale of single cigarettes (also known as singles or loosies) is a key driver for early initiation of smoking and is a leading contributor to the smoking epidemic in India. Sale of singles additionally deter implementation of tobacco control strategies of pictorial health warnings including plain packaging and defeat effective taxation and promote illicit trade. We review India’s tobacco control policy responses towards banning singles and other products sold as loose tobacco and identify opportunities for future policy intervention especially in the context of the ongoing COVID-19 pandemic. Methods: Existing national and sub-national policy documents were analyzed for their content since the inception of the tobacco control laws in the country. Results: There are no effective provisions at national level to ban loose tobacco products in India. However, the implementation of multiple legislative and regulatory measures (Acts/circulars/letters/notifications/orders/court judgements) in 16 Indian states and jurisdictions provide sufficient legal framework to substantiate its complete ban pan India. While the majority of state governments have adopted state level measures, Rajasthan had issued specific directive to all the 33 districts banning loose cigarettes and other tobacco products. Himachal Pradesh introduced the most unique and comprehensive legislation, for banning the sale of cigarettes and beedis (Dated November 7, 2016). The most recent notification in the state of Maharashtra (September 24, 2020) is the first to leverage powers using a mix of national and state legislations including the legislation addressing the rapidly emerging challenge of managing COVID-19. Conclusion: A robust national policy which supports strong provision to deter tobacco companies, their distribution network and vendors from selling singles or loose tobacco products is urgently needed. Such policy should be backed by cautionary messaging for consumers as well. Eliminating singles and loose tobacco sale will help in blunting tobacco use prevalence besides curbing spread of infectious diseases like COVID-19 pandemic.
- 1 November 2021
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 22 (S2) , 51-57
Banning Loose Cigarettes and Other Tobacco Products in India: A Policy Analysis
Background: Sale of single cigarettes (also known as singles or loosies) is a key driver for early initiation of smoking and is a leading contributor to the smoking epidemic in India. Sale of singles additionally deter implementation of tobacco control strategies of pictorial health warnings including plain packaging and defeat effective taxation and promote illicit trade. We review India’s tobacco control policy responses towards banning singles and other products sold as loose tobacco and identify opportunities for future policy intervention especially in the context of the ongoing COVID-19 pandemic. Methods: Existing national and sub-national policy documents were analyzed for their content since the inception of the tobacco control laws in the country. Results: There are no effective provisions at national level to ban loose tobacco products in India. However, the implementation of multiple legislative and regulatory measures (Acts/circulars/letters/notifications/orders/court judgements) in 16 Indian states and jurisdictions provide sufficient legal framework to substantiate its complete ban pan India. While the majority of state governments have adopted state level measures, Rajasthan had issued specific directive to all the 33 districts banning loose cigarettes and other tobacco products. Himachal Pradesh introduced the most unique and comprehensive legislation, for banning the sale of cigarettes and beedis (Dated November 7, 2016). The most recent notification in the state of Maharashtra (September 24, 2020) is the first to leverage powers using a mix of national and state legislations including the legislation addressing the rapidly emerging challenge of managing COVID-19. Conclusion: A robust national policy which supports strong provision to deter tobacco companies, their distribution network and vendors from selling singles or loose tobacco products is urgently needed. Such policy should be backed by cautionary messaging for consumers as well. Eliminating singles and loose tobacco sale will help in blunting tobacco use prevalence besides curbing spread of infectious diseases like COVID-19 pandemic.
- 5 August 2021
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 68, S65-S70
Raising the legal age for purchase and use of tobacco to 21 years: A step towards tobacco endgame in India
- 5 August 2021
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 68, S65-S70
Raising the legal age for purchase and use of tobacco to 21 years: A step towards tobacco endgame in India
- 1 January 2021
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 68, S7-S13
Indirect tobacco advertising, promotion and sponsorships in the Indian Premier League 2020: Tobacco Industry's continuous presence in Indian cricket
- 1 January 2021
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 68, S7-S13
Indirect tobacco advertising, promotion and sponsorships in the Indian Premier League 2020: Tobacco Industry's continuous presence in Indian cricket